Inês C.
- Country
- Portugal
- Department
- Cardiology Department
Research Overview
- A Long-term Safety Extension Study of Mavacamten (MYK-461) in Adults with Hypertrophic Cardiomyopathy Who Have Completed the MAVERICKHCM (MYK-461-006) or EXPLORER-HCM (MYK-461-005) Trials (MAVA-LTE)
- Phase 3 Randomized Study Comparing Asundexian and Apixaban for Stroke Prevention in Atrial Fibrillation Patients at Risk
Data & Insights
Has run more than one trial at 12 of 435 partner sites.
Specializations
Cardiovascular Disease Management
The investigator specializes in treating complex cardiac conditions, with particular emphasis on hypertrophic cardiomyopathy (HCM), including both obstructive and non-obstructive variants. Their research extends to evaluating innovative therapeutic approaches for cardiac mass and structure modifications.
- Obstructive HCM Treatment
- Non-obstructive HCM Management
- Cardiac Structure Assessment
A key focus includes the application of advanced cardiac imaging techniques, particularly cardiac magnetic resonance imaging (CMR) for monitoring treatment outcomes.
Stroke Prevention
The investigator concentrates on preventing stroke and systemic embolism in patients with cardiac arrhythmias. Their expertise includes the evaluation of anticoagulation strategies for patients with atrial fibrillation.
- Anticoagulation Therapy
- Stroke Risk Management
- Bleeding Risk Assessment
Their work includes assessment of bleeding risks according to International Society on Thrombosis and Hemostasis (ISTH) criteria.
Therapeutic Innovation
The investigator evaluates novel therapeutic agents for cardiovascular conditions, focusing on treatments for both structural heart disease and arrhythmia-related complications.
- Long-term Safety Assessment
- Comparative Treatment Efficacy
- Risk-Benefit Analysis
Their research encompasses long-term safety monitoring and therapeutic efficacy evaluation in cardiovascular medicine.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.